| This report contains COVID-19 specific updates.
Nanomaterials in Personalized Medicine: Global Markets
Report Highlights
The global nanomaterials in personalized medicines market should reach $420.0 billion by 2025 from $253.8 billion in 2020 at a compound annual growth rate (CAGR) of 10.6% for the forecast period of 2020 to 2025.
Report Includes
- 43 tables
- A brief outlook of the global market for nanomaterials used in personalized medicine and pharmaceuticals within the industry
- Analyses of the global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- In-depth competitive market analysis of the key industry participants, their company share analysis, global rankings and product offerings
- Estimation of the actual market size and revenue forecasts for nanomaterials used in personalized medicine, and corresponding market share analysis by product type and region for each key market segment
- Discussion of market potential for nanomaterial applications in medicine and pharmaceuticals, industry value chain analysis, technology updates, and market growth drivers within the segment
- Insight into nanomaterial-based treatment methods for infections associated with medical devices and regulatory frameworks for personalized medicine
- Evaluation of global nanotechnology patents and significant allotment of patent data
- Company profiles of the leading industry players, including Novartis AG, Bristol-Myers Squibb Co., Beckman coulter, Merck & Co., Inc and Cytimmune Sciences
Report Scope
The scope of this report includes an overview of the global market for nanomaterials in personalized medicine and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
The report is intended for professionals in the medical, medical devices, pharmaceutical, nanotechnology, materials, chemical, biological, biotechnological, and diagnostics fields. It will enable readers to understand the paradigms of personalized medicine’s new business model. A discussion of the debate between the marketing of a drug with or without its companion diagnostic kit is included. Therefore, this report is valuable for both the pharmaceutical and the medical devices industries.
Additional professionals who may benefit from reading this report include analysts, sales and marketing representatives, R&D personnel, business development personnel, and corporate strategy developers. Investment firms will gain invaluable information concerning risks and opportunities encountered in the field.
Market figures are based on revenues at the manufacturer level and are projected in 2019 dollar values. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products, and other factors affecting the market.
Included in this report are forecasts by product, product category and by company. The study is arranged to offer an overview of existing nanomaterials in personalized medicine; it is accompanied by nanoproduct, company, and mechanism of action, with forecasts broken down.
Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis unless specifically noted.
The report provides valuable insights and guidance for strategic marketing planning, understanding market drivers and limiters, and discerning sales growth opportunities.
Analyst Credentials
BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.
Report Highlights
The global theranostic nanomaterial market was estimated to total nearly $106 billion in 2011 and $112 billion in 2012. The market should total nearly $188 billion by 2017, and have a five-year compound annual growth rate (CAGR) of 10.8%.
This report provides:
- An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics.
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Discussion of the advantages of nanoscale materials, such as in the fabrication of nano-machines that can deliver their cargo (a drug) to a precise location (for instance, the tumor tissue of a specific organ) so that healthy tissues are minimally affected, and in the fabrication of nano-drugs, diagnosis in vivo and therapeutic applications.
- Examination of the role of theranostics in oncology, immunodeficiencies, and cardiovascular and neuro disorders.
- Identification of the types of theranostic agents, such as gold-based, magnetic, polymeric, silica-based, carbon, composite, and lyposome nanomaterials.